Maine Clinical Trials Report — June 2026

For Maine residents considering participation in clinical trials, June 2026 presents a critical window of opportunity, particularly for studies nearing their enrollment deadlines. Across the state, 6 clinical trials are slated to close within the next 90 days, meaning interested individuals should act quickly to explore these options. Among these, 2 trials are still accepting healthy volunteers, offering a chance to contribute to medical science without needing a specific health condition.

Patients living with certain conditions should pay close attention to the trials with impending deadlines. The conditions covered by these closing studies span several areas, from cardiovascular health to rare genetic disorders and eye conditions. If you or someone you know is affected by these, now is the time to investigate further:

• Atrial fibrillation
• Bleeding
• Chronic granulomatous disease (CGD)
• Dry age-related macular degeneration
• Epiretinal membrane
• Food insecurity
• Intraretinal hyporeflective space
• IS/OS (ellipsoid zone) disruption
• Macular abnormalities

A Focused Expansion in Maine's Research Landscape

This June, Maine's clinical research landscape saw a modest expansion with the opening of a single new trial. This contrasts with the 3 new trials that launched in May 2026, indicating a quieter month for new research initiatives. Despite the lower number, the new study addresses a significant health challenge and offers a valuable opportunity for those living with type 1 diabetes.

The notable new trial for June is:

• NCT07676565: "Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study." Sponsored by Indiana University, this registry-based study aims to enroll 300 participants. It will evaluate the safety and efficacy of GLP-1RA and SGLTi therapies when used alongside insulin in adults with type 1 diabetes (T1D) over a 1-year period. This study is designed for individuals who have already been prescribed these adjunct therapies as part of their usual care, making it an observational study of real-world outcomes.

This type 1 diabetes study represents the sole new research opportunity this month and is located in Portland, continuing its role as a key hub for clinical investigations in Maine.

Opportunities for Healthy Volunteers and Diverse Participants

While the single new trial this month does not accept healthy volunteers, there are still avenues for those without specific health conditions to participate in research. As mentioned, 2 of the 6 trials closing soon are still seeking healthy volunteers, providing an urgent opportunity to get involved. More broadly, Maine currently has 13 clinical trials statewide that are actively recruiting healthy volunteers, offering various ways to contribute to medical advancements.

Regarding participant demographics, the new type 1 diabetes trial is designed to include older adults. This ensures that research findings can be more broadly applicable to different age groups within the adult population. No new trials this month are exclusively for children, or specifically for female-only or male-only participants, highlighting a focus on broader adult populations in the latest research.

Maine's Statewide Research Footprint

Maine continues to host a robust clinical research environment, with a total of 199 clinical trials currently recruiting participants. These studies are spread across 28 cities and involve 114 different research sites throughout the state. This broad distribution means that residents in various regions of Maine may find research opportunities closer to home, rather than being concentrated solely in major metropolitan areas.

This month, the only new trial opened in Portland. As Maine's largest city, Portland frequently serves as a central location for clinical research, offering access to specialized medical facilities and a larger population base for recruitment. While this month's new trial is localized, the overall number of recruiting studies demonstrates a widespread commitment to advancing medical knowledge across the state.

A Look at the Trends

The pace of new trial openings in Maine has seen some fluctuation over the past six months. After seeing 2 new trials in January 2026, 1 in February, 3 in March, 2 in April, and a peak of 4 in May, June's single new trial marks a return to a more modest rate of expansion. Looking ahead, current projections indicate 1 new trial is expected to open in July 2026. This trend suggests a steady, albeit sometimes fluctuating, stream of new research opportunities for Maine residents.

As we move further into June, the focus for Maine's clinical research community will be on the continued enrollment in the existing 199 trials and the timely completion of studies nearing their close, ensuring that valuable data is collected to inform future medical practice and innovation.